Diffinity Genomics

DNA purification firm Diffinity will become a business unit of Chiral following the completion of the deal.

Cepheid disclosed in a filing with the US Securities and Exchange Commission this week that it has terminated the employment of Nicolaas Arnold, its executive vice president of worldwide commercial operations.

People In The News

NEW YORK (GenomeWeb News) – AssureRx Health, a neuropsychiatric personalized medicine company, has formed a scientific advisory board, which will guide the company's R&D efforts on pharmacogenomic products.

NEW YORK (GenomeWeb News) – Diffinity Genomics has won a pair of grants worth a total of $700,000 from the National Institutes of Health to support the company's ongoing development of new technologies and products for rapid nucleic acid purification using specialized pipette tips.

Diffinity Genomics this month won a pair of grants worth a total of $700,000 from the National Institutes of Health to support the company's ongoing development of new technologies and products for rapid nucleic acid purification using specialized pipette tips.

NEW YORK (GenomeWeb News) – Roche will shutter its NimbleGen microarray business, and will phase out array production and services by the end of the year.

Diffinity Genomics said this week that it has closed a Series B financing.

Diffinity Genomics has launched the Diffinity RapidTip2 for PCR purification and polymerase removal prior to cloning or Sanger sequencing.

Diffinity Genomics said this week that it has signed a non-exclusive agreement with Sigma-Aldrich to distribute the Diffinity RapidTip PCR purification product worldwide.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.